NeevoDHA, prenatal vitamin with docosahexaenoic acid, has been launched by Pamlab toexpand its line of Neevo products. It is indicated for nutritional supplementduring pregnancy, prenatal, and postnatal periods in women with or at risk forfolate 667C>T polymorphism and/or women who are associated with immediate tohigher risk pregnancies. 

NeevoDHA is expected to be available in mid-March 2009 in a 30 countbottle. 

Formore information call (985) 893-4097 or visitwww.neevoprenatal.com.